High materiality7/10
Immunocore price target raised to $43 from $40 at Morgan Stanley
Why it may matterVerify against the original reporting
Upside implied by target above current price.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Morgan Stanley raises IMCR target to $43 from $40; current price $33.26.
- Target raised to $43; price $33.26.
Key facts
- 01
Target: $43
- 02
Posted price: $33.26
- 03
Analyst firm: Morgan Stanley
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.